Mimetogen Pharmaceuticals Appoints Kim Brazzell, Ph.D. as Chief Medical Officer
1/5/2012 7:57:36 AM
More...
|
Mimetogen Pharmaceuticals Announces Positive Top Line Data from Phase II Clinical Trial of MIM-D3 for Dry Eye Disease
6/27/2011 10:55:23 AM
More...
|
Mimetogen Pharmaceuticals Announces Positive Top Line Data from Phase II Clinical Trial of MIM-D3 for Dry Eye Disease
6/27/2011 8:27:55 AM
More...
|
Mimetogen Pharmaceuticals Completes Key Equity Financing for Ophthalmology Drugs
10/7/2009 8:28:12 AM
More...
|